🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Betw...
Status
Unknown
Location
Lexicon Investigational Site
Start Date
2015-07
Trial ID
NCT02494609
Treatments Being Tested
The purpose of this study is to demonstrate a lack of effect of venlafaxine...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-12
Trial ID
NCT02637193
Treatments Being Tested
An open label, balanced, randomized, two-treatment, two-period, two-sequenc...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT02322619
Treatments Being Tested
The main objective of this trial is to evaluate the effects of a single the...
Status
Completed
Location
Quotient Sciences
Start Date
2024-03-06
Trial ID
NCT06107036
Treatments Being Tested
The purpose of this study is to demonstrate a lack of effect of sertraline ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-01
Trial ID
NCT02651623
Treatments Being Tested
This study is being performed to investigate the potential for AZD5672 to a...
Status
Completed
Location
Research Site
Start Date
2009-04
Trial ID
NCT00887770
The purpose of this study is to determine whether BMS-791325 has an effect ...
Status
Completed
Location
Ppd Development, Llc
Start Date
2014-04
Trial ID
NCT02084953
Treatments Being Tested
This is a single dose study in healthy male volunteers to investigate the e...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01290900
Treatments Being Tested
To demonstrate that tiotropium (Spiriva®) does not prolong the QT interval ...
Status
Completed
Location
Humanpharmakologisches Zentrum
Start Date
2004-10
Trial ID
NCT00257452
Treatments Being Tested
Study to assess the effect of Selumetinib \[AZD6244; ARRY-142886\] \[Hyd-Su...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02056392
Treatments Being Tested